NCT05850416

mGlide-Care: A Partnership With Caregivers

mGlide-Care: A Partnership With Caregivers to Improve HTN Management in Patients With Cognitive Impairment

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 60 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Hypertension (HTN) is the most significant stroke, cardiovascular disease and dementia risk factor and is substantially under-treated especially in older persons. In this study the investigators will develop mGlide-Care to address uncontrolled HTN in people with mild cognitive impairment (MCI) and early stage Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD). mGlide-Care is adapted from mGlide which is a mHealth (mobile health technology) mediated care model for HTN care. Aim 1 will engage stakeholders to study the acceptability of mHealth mediated HTN care and will use their input to develop mGlide-Care. Stakeholders are persons with early stage AD/ADRD and MCI, unpaid family caregivers, primary care providers, geriatricians and clinical pharmacists. Aim 2 is a feasibility pilot to test mGlide-Care vs. usual care in 75 participants with uncontrolled HTN and early stage AD/ADRD or MCI. Caregivers will assist participants. Outcomes will include HTN control and participant and caregiver reported measures.

Conditions

• HTN

Interventions

Type	Name	Description
OTHER	mGlide-Care	Mhealth mediated model of HTN care with self-monitoring and medication management
OTHER	Usual Care +	Usual Care with self-monitoring support

Timeline

• Start date: 2026-01-15
• Primary completion: 2028-05-30
• Completion: 2028-05-30
• First posted: 2023-05-09
• Last updated: 2026-02-13

Locations

1 site across 1 country: United States